How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Micron Technology Inc. | €177.94 | €170.94 |
| NVIDIA Corp. | €156.80 | €175.30 |
| Bank of America Corp. | €44.58 | €48.72 |
| Security | Price | Target price |
|---|---|---|
| Clorox Co. | €101.00 | €95.56 |
| Consolidated Edison Inc. | €86.74 | €86.41 |
| Mira Pharmaceuticals Inc. | €1.23 | - |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Beyond Meat Inc | Bankster | 348.88% |
| B Carpenter Technology | Jones Trading | 22.64% |
| B Halliburton Co. | Stifel Nicolaus | 19.99% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Beyond Meat Inc | Wolf_of_WS | -63.73% |
| S Minerva Neurosciences Inc. | Global_Player | -55.71% |
| S Beyond Meat Inc | Global_Player | -47.99% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
Quantum Emotion Corp. 1000%
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
Scienture Holdings Inc.
WKN: A40QA7 / Name: Scienture Holdings Inc. / Stock / ? /
Pros
Cons
Mira Pharmaceuticals Inc.
WKN: A3EQWL / Name: Mira Pharmaceuticals Inc. / Stock / ? /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Las Vegas Sands Corp. | €48.99 | 13.680% |
| Dow Inc. | €21.20 | 12.830% |
| Lumen Technologies Inc. | €6.70 | 11.120% |
| Helmerich & Payne Inc | €22.12 | 7.650% |
| APA Corporation | €21.20 | 7.050% |
| Security | Price | Change(%) (%) |
|---|---|---|
| United Rentals Inc. | €787.00 | -7.400% |
| Roper Industries Inc. | €413.30 | -6.110% |
| Southwest Airlines Co. | €27.25 | -5.760% |
| Textron Inc. | €68.42 | -5.140% |
| Centene Corp. | €29.57 | -5.010% |
Courses
sharewise Introduction
sharewise advanced features
Also you get more information about our Pro and Cons feature, where we bring the wisdom of crowds to a new level.
For discussing with your friends and managing your investment clubs we will show you how to create your own stock debates.#
Predictions
Top News
Boeing Takes Off as FAA Greenlights 737 MAX Production Boost
A major operational overhang for The Boeing Company (NYSE: BA) has been lifted, propelling the aerospace sector giant’s stock higher. On Oct. 17, 2025, the Federal Aviation Administration (FAA)
![Top 130 Streets for Fall Shopping [2025 Survey]: https://www.marketbeat.com/logos/articles/med_20251023132444_top-130-streets-for-fall-shopping-2025-survey.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMHFvYmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--503cb2ae66151ce995038f50ad39a61f84830374/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20251023132444_top-130-streets-for-fall-shopping-2025-survey.png?locale=us)
Top 130 Streets for Fall Shopping [2025 Survey]
Every fall, America’s main streets prove that local life still has a pulse. The pumpkins, festivals, and shopfront lights aren’t just seasonal decor – they are signs that small-town commerce
Capital One Just Flashed a Buy Signal—New Highs Could Be Next
Capital One Financial Corp. (NYSE: COF) left no room for doubt for investors who may have been sitting on the fence.
The company delivered a stellar earnings report. Based on the stock price
GM Posts Largest Gain Since the Pandemic: Shares Still Look Cheap
Shares of Detroit Three automaker General Motors (NYSE: GM) have been underwater for most of 2025, with tariffs, EV difficulties, and economic uncertainty depressing sentiment. However, things
3 Pharmaceutical Growth Stocks to Buy and Hold for 10 Years
For many investors, getting involved with pharmaceutical stocks involves finding inexpensive stocks, often penny stocks, in hopes of investing in a breakthrough treatment for cancer, Alzheimer’s
Why Rigetti Stock is Up 2,800% and What Happens Next
Rigetti Computing, Inc.’s RGTI shares have gained more than 2,800% in the past year as investors showed excitement over its quantum breakthroughs. However, Rigetti’s weak fundamentals and lofty
4 Low-PEG GARP Stocks That Perfectly Balance Growth and Value
Over the past few months, the market cacophony has made hybrid investment particularly relevant. While volatility remains elevated amid global policy uncertainty and uneven sectoral growth, the
Viking Therapeutics Posts Wider-Than-Expected Loss in Q3, Sales Nil
Viking Therapeutics VKTX reported a third-quarter 2025 loss of 81 cents per share, wider than the Zacks Consensus Estimate of a loss of 70 cents. The company had incurred a loss of 22 cents per
Texas Capital Q3 Earnings Beat on Strong NII, Expenses Decline Y/Y
Texas Capital Bancshares, Inc. TCBI reported record third-quarter 2025 earnings per share (EPS) of $2.18, which surpassed the Zacks Consensus Estimate of $1.77. Further, the figure also compared
Rubrik's Cloud Security Platform Expands: A Sign for More Upside?
Rubrik RBRK is benefiting from the rapid expansion of its cloud security platform, which has become a key driver of its growth and market leadership in cyber resilience. In the second quarter of
BV Financial's Q3 Earnings Climb Y/Y on Loan Growth, Stock Up 14%
Shares of BV Financial, Inc. BVFL have gained 13.9% since the company reported its earnings for the quarter ended Sept. 30, 2025. This compares to the S&P 500 index’s 1.4% growth over the same time
News
UiPath Strengthens Its Position as AI Fuels Automation Expansion
UiPath PATH is sustaining its 2025 growth trajectory by leveraging its cutting-edge AI-powered enterprise automation platform, a key driver of long-term value.
In its recent quarterly results, PATH
CBRE Group Q3 Earnings Beat Estimates, 2025 EPS Outlook Raised
CBRE Group Inc. CBRE reported third-quarter 2025 core earnings per share (EPS) of $1.61, ahead of the Zacks Consensus Estimate of $1.47. The reported figure also increased 34.2% year over year.
Strategy Drops 13% in a Month: Buy, Sell or Hold the MSTR Stock?
Strategy MSTR shares have dropped 13.1% in the past month, underperforming the Zacks Financial- Miscellaneous Services industry’s and the broader Zacks Finance sector’s fall of 3.7% and 1.4%
TER Gears Up to Report Q3 Earnings: What's in Store for the Stock?
Teradyne TER is set to report its third-quarter 2025 results on Oct. 28, 2025.For the third quarter of 2025, TER expects revenues between $710 million and $770 million. The company anticipates
MSCI Set to Report Q3 Earnings: What's in Store for the Stock?
MSCI MSCI is set to report its third-quarter 2025 results on Oct. 28, 2025.The Zacks Consensus Estimate for earnings is currently pegged at $4.37 per share, which has been steady over the past 30
Navient's Q3 Earnings on the Deck: Here's What You Should Know
Navient Corporation NAVI is scheduled to report third-quarter 2025 results on Oct. 29, before the opening bell. Its quarterly revenues are expected to have risen, while earnings are expected to have
Vertiv Q3 Earnings Beat Estimates, Net Sales Up Y/Y, Shares Rise
Vertiv Holdings VRT reported third-quarter 2025 non-GAAP earnings of $1.24 per share, beating the Zacks Consensus Estimate by 24%. The figure jumped 63.2% year over year.Net sales increased 29% year
Is TeraWulf Stock's 31.18X PB Still Worth it? Buy, Sell, or Hold?
TeraWulf WULF shares are currently overvalued, as suggested by the Value Score of F. In terms of price/book, TeraWulf is trading at 31.18X compared with the Zacks Financial- Miscellaneous Services
Contest
Still running
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.